Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice

Department of Physiology, Cardiovascular Research & Development Unit, Faculty of Medicine, University of Porto, Portugal.
Life Sciences (Impact Factor: 2.7). 09/2008; 83(13-14):502-10. DOI: 10.1016/j.lfs.2008.07.021
Source: PubMed


Although toll-like receptors (TLR) are known to mediate the metabolic complications of obesity, the mechanisms underlying its activation remain largely unknown. The present study analyzed a model of diet-induced obesity in mice lacking the TLR4/TLR2 co-receptor CD14.
Six-week-old male mice lacking CD14 (n = 16) were allocated to either a control diet or a high-fat high-simple carbohydrate diet (5.4 kcal/g; 35% fat; 35% sucrose), and compared with C57BL/6 (WT; n = 15) controls. After 12 weeks, body composition, basal sympathetic activity, non-invasive blood pressure and glucose tolerance were evaluated. Hepatic and adipose tissues were collected for mRNA quantification, histology and LPS incubation.
In both WT and CD14 knockout mice, obesity was accompanied by TLR2 and TLR4 upregulation. However, obese mice lacking CD14 presented decreased lipid and macrophage content in hepatic and adipose tissues, lower urinary levels of noradrenaline, decreased systolic blood pressure, reduced fasting plasma glucose and blunted glucose intolerance, compared with obese WT group. In the presence of exogenous sCD14, adipose tissue incubation with LPS-induced TLR2 and TNF-alpha upregulation in both WT and CD14 knockout obese mice.
In our model of diet-induced obesity, mice lacking CD14 showed lower adiposity and hepatic steatosis, improved glucose homeostasis, blunted sympathetic overactivity and reduced blood pressure elevation. This was observed in the presence of preserved TLR4 and TLR2 gene expression, and intact TLR4 signaling pathways. These results suggest that CD14-mediated TLR activation might contribute to the cardiovascular and metabolic complications of obesity.

Download full-text


Available from: André Lourenço
  • Source
    • "Recent advances in CD14 biology have confirmed its role not only as the TLR co-receptor but also as a PRR (Zanoni et al., 2009, 2011). Moreover, in addition to the functions in innate immunity (Ostuni et al., 2010), a more general role for CD14 in regulating metabolism, insulin resistance, and obesity is emerging (Johnson et al., 2004; Roncon-Albuquerque et al., 2008; Fernandez-Real et al., 2011). The purpose of this mini-review is to give an "
    [Show abstract] [Hide abstract]
    ABSTRACT: CD14 is a glycosylphosphatidylinositol (GPI)-anchored receptor known to serve as a co-receptor for several Toll-like Receptors (TLRs) both at the cell surface and in the endosomal compartment. CD14 can be expressed by cells of both hematopoietic and non-hematopoietic origin as a cell membrane or secreted protein. Although CD14 was discovered more than 20 years ago, its activities remain largely to be defined. Most of the information available concerns CD14's role as a co-receptor working with TLR4 and facilitating cellular responses to low doses of lipopolysaccharide (LPS). Recent studies have highlighted and molecularly defined many other functions of this pattern recognition receptor (PRR). These functions include the mechanisms through which CD14 allows the activation of the TLR4-TRAM-TRIF pathway upon LPS stimulation; the capacity of CD14 to transduce a TLR4-independent signaling pathway leading to the activation of NFAT transcription factor family members with important consequences in myeloid cells; the CD14 influence on cell metabolism in conditions predisposing to obesity. In this review, we summarize recent progresses toward the molecular definition of the multiple roles exerted by CD14 in innate immune cells in response to LPS and the consequences of CD14 activation in physiologic and pathologic conditions.
    Full-text · Article · Jul 2013 · Frontiers in Cellular and Infection Microbiology
  • Source
    • "It should be noted that the relative increases in fat mass and body weight due to LPS administration or the high-fat/carbohydrate-free diet that we used in this protocol were lower than those observed with a western-type diet. Nevertheless, other studies favour this hypothesis because in the absence of the LPS receptor (CD14 −/− or TLR-4 −/− models), mice are resistant to diet-induced metabolic disorders (Cani et al., 2007a; Tsukumo et al., 2007; Davis et al., 2008; Roncon-Albuquerque et al., 2008). The role of gut microbiota-derived LPS as a factor triggering low-grade inflammation, type 2 diabetes and insulin resistance was subsequently investigated in both nutritionally and genetically obese mice through specific modulation of the composition of the gut microbiota (Cani et al., 2008; Membrez et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity, type-2 diabetes and low-grade inflammation are becoming worldwide epidemics. In this regard, the literature provides a novel concept that we call "MicrObesity" (Microbes and Obesity), which is devoted to deciphering the specific role of dysbiosis and its impact on host metabolism and energy storage. In the present review, we discuss novel findings that may partly explain how the microbial community participates in the development of the fat mass development, insulin resistance and low-grade inflammation that characterise obesity. In recent years, numerous mechanisms have been proposed and several proteins identified. Amongst the key players involved in the control of fat mass development, Fasting induced adipose factor, AMP-activated protein kinase, G-protein coupled receptor 41 and G-protein coupled receptor 43 have been linked to gut microbiota. In addition, the discovery that low-grade inflammation might be directly linked to the gut microbiota through metabolic endotoxaemia (elevated plasma lipopolysaccharide levels) has led to the identification of novel mechanisms involved in the control of the gut barrier. Amongst these, the impacts of glucagon-like peptide-2, the endocannabinoid system and specific bacteria (e.g., Bifidobacterium spp.) have been investigated. Moreover, the advent of probiotic and prebiotic treatments appears to be a promising "pharmaco-nutritional" approach to reversing the host metabolic alterations linked to the dysbiosis observed in obesity. Although novel powerful molecular system biology approaches have offered great insight into this "small world within", more studies are needed to unravel how specific changes in the gut microbial community might affect or counteract the development of obesity and related disorders.
    Full-text · Article · Feb 2011 · Pharmacology [?] Therapeutics
  • Source
    • "Unless the statistical approach considers this nesting, the correlation will lead to an inflated estimate of statistical significance and thus type I errors (Hulbert 1984). Current users have addressed this by using a standard Student's t test on the mean of means (Cho et al. 2008; Krege et al. 1995; Roncon-Albuquerque et al. 2008; Whitesall et al. 2004). An alternative approach is to use a nested ANOVA, which models the covariance structure introduced by the grouping of the data. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To further the functional annotation of the mammalian genome, the Sanger Mouse Genetics Programme aims to generate and characterise knockout mice in a high-throughput manner. Annually, approximately 200 lines of knockout mice will be characterised using a standardised battery of phenotyping tests covering key disease indications ranging from obesity to sensory acuity. From these findings secondary centres will select putative mutants of interest for more in-depth, confirmatory experiments. Optimising experimental design and data analysis is essential to maximise output using the resources with greatest efficiency, thereby attaining our biological objective of understanding the role of genes in normal development and disease. This study uses the example of the noninvasive blood pressure test to demonstrate how statistical investigation is important for generating meaningful, reliable results and assessing the design for the defined research objectives. The analysis adjusts for the multiple-testing problem by applying the false discovery rate, which controls the number of false calls within those highlighted as significant. A variance analysis finds that the variation between mice dominates this assay. These variance measures were used to examine the interplay between days, readings, and number of mice on power, the ability to detect change. If an experiment is underpowered, we cannot conclude whether failure to detect a biological difference arises from low power or lack of a distinct phenotype, hence the mice are subjected to testing without gain. Consequently, in confirmatory studies, a power analysis along with the 3Rs can provide justification to increase the number of mice used. Electronic supplementary material The online version of this article (doi:10.1007/s00335-010-9279-1) contains supplementary material, which is available to authorized users.
    Full-text · Article · Oct 2010 · Mammalian Genome
Show more